BSE filing, NSE: INDRAMEDCO. Summary written from the filing by ALFA Finder's alert engine.
Indraprastha Medical Corporation Ltd: key numbers
- Share price
- ₹310.65
- Market cap
- ₹2,848 Cr
- Revenue (annual)
- ₹1,483 Cr
- Net profit (annual)
- ₹183.6 Cr
- P/E (TTM)
- 14.8×Sector 53.7×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 2.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indraprastha Medical Corporation Ltd
All →Indraprastha Medical Corporation Q2 FY27 Results: Net Profit ₹53.6 Cr, Up 8.3% YoY
Indraprastha Medical reported Q2FY27 revenue from operations of Rs 412.85 crore and PAT of Rs 53.58 crore. Half-year PAT rose to Rs 109.43 crore from Rs 100.92 crore a year earlier.
- Key figure
- Net profit ₹53.6 Cr · +8.3% YoY
Indraprastha Medical Corporation Board Meeting Date
Indraprastha Medical Corporation will hold a board meeting on 29 Oct 2026 to consider Q1 FY27 unaudited standalone financial results. The trading window is closed from 1 Oct to 31 Oct 2026.
Indraprastha Medical Corporation Other Announcement
The Company has filed its quarterly shareholding pattern as mandated by Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Ltd announced voting results for its AGM held on September 24, 2026. Shareholders approved a dividend of Rs. 4.00 per equity share.
- Value
- ₹36.67 Cr
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Limited held its 38th AGM on September 24, 2026. Shareholders considered resolutions including a Rs. 4.00 per share dividend declaration.
Indraprastha Medical Corporation Annual Report
Indraprastha Medical Corporation Limited has released its Annual Report for FY 2025-26. The 38th Annual General Meeting is scheduled for September 24, 2026.
Other debt & borrowing announcements
All →Regency Fincorp Debt & Borrowing: ₹100 Cr
Regency Fincorp corrected its NCD private placement size from 75,000 to 1,00,000 units. The revised aggregate issue amount is ₹100 Crore with a 15-month tenure.
- Value
- ₹100.0 Cr
Viviana Power Tech Debt & Borrowing
Viviana Power Tech filed its security cover certificate for secured NCDs at 30 September 2026. Trade receivables security stood at Rs. 18,079.71 lakh, covenants met.
Ventive Hospitality Debt & Borrowing: ₹200 Cr
Ventive approved a letter of comfort to ICICI Bank for its subsidiary's Rs 200 crore loan. It rescinded an earlier HSBC shortfall undertaking for the same facility.
- Value
- ₹200.0 Cr
Poonawalla Fincorp Debt & Borrowing: ₹10 Cr
Poonawalla Fincorp fully redeemed its Rs 10 Crore NCDs on 02 November 2026 and paid interest on time. Interest paid was Rs 39,130, net of TDS.
- Value
- ₹10.00 Cr
Annvrridhhi Ventures Debt & Borrowing: ₹25.1 Cr
Annvrridhhi Ventures signed a ₹25.10 crore working capital credit facility with Punjab National Bank. The loan is secured by promoter guarantees and property mortgages.
- Value
- ₹25.10 Cr
RRIL Debt & Borrowing: ₹150 Cr
RRIL Limited's board approved raising its Section 180/186 borrowing and investment limits to Rs.500 Crore, subject to shareholder approval. It also approved a corporate guarantee of up to Rs.150 Crore for subsidiary Sumati Spintex.
- Value
- ₹150.0 Cr